News | December 10, 2023
Briefs: GlaxoSmithKline Pharmaceuticals and Dr. Reddy's Laboratories
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
Express Scripts to add Zepbound to National Preferred Formulary
The company has received Form 483 with three observations
Laurus Labs concluded the acquisition by securing the remaining 8,333 equity shares from the promoter group shareholders
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
Phase 3 data expected in the second half of 2024
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
The collaboration brings a seamless digital experience to more formulators worldwide
Divi's Laboratories Limited has reported total income of Rs. 1995 crores during the period ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated
